Japan’s Takeda to sell some Asia-focused drugs to Celltrion for $278 million

Published by Muller&Green at June 11, 2020

Tags

Takeda Pharmaceutical Co Ltd has agreed to sell a portfolio of over-the-counter and prescription drugs marketed in the Asia Pacific region to South Korea’s Celltrion Inc for $278 million, it said on Thursday

Muller&Green

Exclusive: Pershing Square’s Ackman eyes $1 billion-plus ‘blank-check’ company – sources

Oil prices set for worst daily drop since April on inventories, bearish Fed

Japan’s Takeda to sell some Asia-focused drugs to Celltrion for $278 million

Muller&Green

Related posts

The Price of Gold Keeps Climbing. Here’s What to Know

American Airlines Plane Catches Fire at Denver Airport Gate

Why the U.S. Doesn’t Vaccinate Poultry Against Bird Flu

Exclusive: Pershing Square’s Ackman eyes $1 billion-plus ‘blank-check’ company – sources

Oil prices set for worst daily drop since April on inventories, bearish Fed